Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from SS Innovations International ( (SSII) ).
On May 27, 2025, SS Innovations International announced that its SSi Mantra surgical robotic system had successfully performed over 4,000 surgeries across more than 100 types without complications. This milestone highlights the system’s quality and acceptance, particularly in India, where the company leads the market. The SSi Mantra is approved in seven countries, and the company is working towards entering the U.S. and EU markets, with regulatory decisions expected in late 2025 and early 2026, respectively.
Spark’s Take on SSII Stock
According to Spark, TipRanks’ AI Analyst, SSII is a Neutral.
SS Innovations International’s score is supported by strong corporate events indicating growth potential. However, financial performance and valuation concerns highlight significant risks, with mixed technical signals.
To see Spark’s full report on SSII stock, click here.
More about SS Innovations International
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make robotic surgery affordable and accessible globally. The company’s product range includes the SSi Mantra surgical robotic system and SSi Mudra surgical instruments, supporting various surgical procedures, including robotic cardiac surgery. Headquartered in India, SS Innovations aims to expand its global presence with advanced, user-friendly, and cost-effective solutions.
Average Trading Volume: 44,424
Technical Sentiment Signal: Buy
Current Market Cap: $1.71B
For an in-depth examination of SSII stock, go to TipRanks’ Stock Analysis page.